Loading insider details...
Beta
Latest Form 4 (Aug 20, 2024): Disposition to Issuer of 170,000 MORF shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2024 | Morphic Holding, Inc. (MORF) | Disposition to Issuer | 170,000 | n/a |
| Mar 19, 2024 | Morphic Holding, Inc. (MORF) | Grant/Award | 170,000 | n/a |
| Feb 16, 2024 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 40,000 | n/a |
| Feb 17, 2023 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 40,000 | n/a |
| Jan 25, 2022 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 50,000 | n/a |
| Aug 11, 2021 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 60,000 | n/a |